Currently, the serum prostate-specific antigen (PSA) diagnostic test plays a pivotal role in detecting the vast majority of PCa cases at an early stage, where the tumor is typically localized within the prostatic gland (referred to as organ-localized PCa) [5]. The gene discussed is KLK3; the disease is posterior cortical atrophy.